These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8528370)

  • 1. Long-term effects of tacrine on regional cerebral blood flow changes in Alzheimer's disease.
    Minthon L; Nilsson K; Edvinsson L; Wendt PE; Gustafson L
    Dementia; 1995; 6(5):245-51. PubMed ID: 8528370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physostigmine and tetrahydroaminoacridine treatment of Alzheimer's disease.
    Gustafson L
    Acta Neurol Scand Suppl; 1993; 149(Rand):39-41. PubMed ID: 8128836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral tetrahydroaminoacridine treatment of Alzheimer's disease evaluated clinically and by regional cerebral blood flow and EEG.
    Minthon L; Gustafson L; Dalfelt G; Hagberg B; Nilsson K; Risberg J; Rosén I; Seiving B; Wendt PE
    Dementia; 1993; 4(1):32-42. PubMed ID: 8358504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of long-term treatment with tacrine (THA) in Alzheimer's disease as visualized by PET.
    Nordberg A
    Acta Neurol Scand Suppl; 1993; 149():62-5. PubMed ID: 8128843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tacrine treatment in Alzheimer's disease enhances cerebral blood flow and mental status and decreases caregiver suffering.
    Harkins SW; Taylor JR; Mattay V; Regelson W
    Ann N Y Acad Sci; 1997 Sep; 826():472-4. PubMed ID: 9329726
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of the regional cerebral blood flow changes during long-term donepezil therapy in patients with Alzheimer's disease using 3DSRT.
    Kimura N; Kumamoto T; Masuda T; Hanaoka T; Okazaki T; Arakawa R
    J Neuroimaging; 2012 Jul; 22(3):299-304. PubMed ID: 21699607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term treatment with tacrine (THA) in Alzheimer's disease--evaluation of neuropsychological data.
    Amberla K; Nordberg A; Viitanen M; Winblad B
    Acta Neurol Scand Suppl; 1993; 149():55-7. PubMed ID: 8128841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Response to tacrine in patients with dementia of the Alzheimer's type: cerebral perfusion change is related to change in mental status.
    Harkins SW; Taylor JR; Mattay VS
    Int J Neurosci; 1996 Feb; 84(1-4):149-56. PubMed ID: 8707476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional cerebral blood flow in Alzheimer's disease: comparison between short and long-term donepezil therapy.
    Ushuijima Y; Okuyama C; Mori S; Kubota T; Nakai T; Nishimura T
    Ann Nucl Med; 2006 Jul; 20(6):425-9. PubMed ID: 16922471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholinergic enhancement increases regional cerebral blood flow to the posterior cingulate cortex in mild Alzheimer's disease.
    Iizuka T; Kameyama M
    Geriatr Gerontol Int; 2017 Jun; 17(6):951-958. PubMed ID: 27215917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in regional cerebral blood flow associated with a 45 day course of the ketogenic agent, caprylidene, in patients with mild to moderate Alzheimer's disease: Results of a randomized, double-blinded, pilot study.
    Torosyan N; Sethanandha C; Grill JD; Dilley ML; Lee J; Cummings JL; Ossinalde C; Silverman DH
    Exp Gerontol; 2018 Oct; 111():118-121. PubMed ID: 30006299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group.
    Davis KL; Thal LJ; Gamzu ER; Davis CS; Woolson RF; Gracon SI; Drachman DA; Schneider LS; Whitehouse PJ; Hoover TM
    N Engl J Med; 1992 Oct; 327(18):1253-9. PubMed ID: 1406817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Responder characteristics to a single oral dose of cholinesterase inhibitor: a double-blind placebo-controlled study with tacrine in Alzheimer patients.
    Almkvist O; Jelic V; Amberla K; Hellström-Lindahl E; Meurling L; Nordberg A
    Dement Geriatr Cogn Disord; 2001; 12(1):22-32. PubMed ID: 11125238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The acetylcholine releaser linopirdine increases parietal regional cerebral blood flow in Alzheimer's disease.
    van Dyck CH; Lin CH; Robinson R; Cellar J; Smith EO; Nelson JC; Arnsten AF; Hoffer PB
    Psychopharmacology (Berl); 1997 Aug; 132(3):217-26. PubMed ID: 9292621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal changes in quantitative EEG during long-term tacrine treatment of patients with Alzheimer's disease.
    Jelic V; Dierks T; Amberla K; Almkvist O; Winblad B; Nordberg A
    Neurosci Lett; 1998 Sep; 254(2):85-8. PubMed ID: 9779926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a single dose of the acetylcholinesterase inhibitor velnacrine on recognition memory and regional cerebral blood flow in Alzheimer's disease.
    Ebmeier KP; Hunter R; Curran SM; Dougal NJ; Murray CL; Wyper DJ; Patterson J; Hanson MT; Siegfried K; Goodwin GM
    Psychopharmacology (Berl); 1992; 108(1-2):103-9. PubMed ID: 1410128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging of nicotinic and muscarinic receptors in Alzheimer's disease: effect of tacrine treatment.
    Nordberg A; Lundqvist H; Hartvig P; Andersson J; Johansson M; Hellstrŏm-Lindahi E; Långström B
    Dement Geriatr Cogn Disord; 1997; 8(2):78-84. PubMed ID: 9065319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tacrine (tetrahydroaminoacridine; THA) and lecithin in senile dementia of the Alzheimer type: a multicentre trial. Groupe Français d'Etude de la Tetrahydroaminoacridine.
    Chatellier G; Lacomblez L
    BMJ; 1990 Feb; 300(6723):495-9. PubMed ID: 2107926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SPECT follow-up study of cerebral blood flow changes during Donepezil therapy in patients with Alzheimer's disease.
    Shimizu S; Hanyu H; Iwamoto T; Koizumi K; Abe K
    J Neuroimaging; 2006 Jan; 16(1):16-23. PubMed ID: 16483272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of tacrine hydrochloride (Cognex) in two parallel-group studies.
    Gracon SI
    Acta Neurol Scand Suppl; 1996; 165():114-22. PubMed ID: 8740998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.